PMID- 15927242
OWN - NLM
STAT- MEDLINE
DCOM- 20050908
LR  - 20191210
IS  - 0091-3057 (Print)
IS  - 0091-3057 (Linking)
VI  - 81
IP  - 2
DP  - 2005 Jun
TI  - Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction.
PG  - 407-16
FAU - Sala, Mariaelvina
AU  - Sala M
AD  - Department of Pharmacology, Chemotherapy and medical Toxicology, Faculty of 
      Sciences, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy. 
      mariaelvina.sala@unimi.it
FAU - Braida, Daniela
AU  - Braida D
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Pharmacol Biochem Behav
JT  - Pharmacology, biochemistry, and behavior
JID - 0367050
RN  - 0 (Cannabinoid Receptor Modulators)
RN  - 0 (Endocannabinoids)
RN  - 0 (Hallucinogens)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Animals
MH  - Cannabinoid Receptor Modulators/*pharmacology
MH  - Cannabis
MH  - Drug Interactions
MH  - *Endocannabinoids
MH  - Hallucinogens/*pharmacology
MH  - Humans
MH  - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology
MH  - Neurotoxicity Syndromes/physiopathology
MH  - Reinforcement, Psychology
MH  - Reward
RF  - 122
EDAT- 2005/06/02 09:00
MHDA- 2005/09/09 09:00
CRDT- 2005/06/02 09:00
PHST- 2004/05/21 00:00 [received]
PHST- 2005/02/14 00:00 [revised]
PHST- 2005/02/14 00:00 [accepted]
PHST- 2005/06/02 09:00 [pubmed]
PHST- 2005/09/09 09:00 [medline]
PHST- 2005/06/02 09:00 [entrez]
AID - S0091-3057(05)00136-X [pii]
AID - 10.1016/j.pbb.2005.02.016 [doi]
PST - ppublish
SO  - Pharmacol Biochem Behav. 2005 Jun;81(2):407-16. doi: 10.1016/j.pbb.2005.02.016.